Biohit Oyj : Financial Reporting and Annual General Meeting in 2026

About this update from Biohit Oyj Class B

English Finnish Published: 2025-11-26 13:00:00 CET Biohit Oyj - Financial Calendar Biohit Oyj's Financial Reporting and Annual General Meeting in 2026 Biohit Oyj's Financial Reporting and Annual General Meeting in 2026 Biohit Oyj, Stock Exchange Release November 26 th , 2025, at 2:00 pm (EET) Biohit Oyj's planned release schedule for financial reports in 2026 is as follows: Financial Statement Release for 2025 on Wednesday February 11 th , 2026, at 9:30 am. The Annual Report, including Financial Statement and Report of the Board of Directors for 2025 on Wednesday March 18 th , 2026, at 9:30 am. Half-year financial report for January-June 2026 on Wednesday August 5 th , 2026, at 9:30 am. Biohit observes a silent period of 30 days before results are published. During this period, Biohit's management and other personnel will not provide information about the company's financial position or market related comments, nor will they meet with representatives from equity markets or the financial media. The published financial reports and other stock exchange releases are available on Biohit's website at: https://investors.biohithealthcare.com/en/ . The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at: https://investors.biohithealthcare.com/en/releases/subscribe . Biohit Oyj's Annual General Meeting has been planned for Wednesday June 3 rd , 2026, at 2:00 pm. The Board of Directors will call the General meeting later. Additional information: Jussi Hahtela, CEO, Biohit Oyj tel. +358 50 383 5948 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. https://www.biohithealthcare.com/en Company News Subscribe European Market Activity Nasdaq Europe © 2025, Nasdaq, Inc. All Rights Reserved.

View stock analysis, news, and events for Biohit Oyj Class B